Search Results

ANEW MEDICAL, INC. announces a strategic partnership with Drs. Makoto Suzuki, Craig and Bradley Willcox, Richard Allsopp, and Michio Shimabukuro of Japan’s Okinawa Research Center for Longevity Science for the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.

Glucotrack, Inc. and The Technology Partnership, announced the completion of computational modeling for Glucotrack’s implantable Continuous Blood Glucose Monitor, suggesting sensor longevity beyond three years, a year longer than the Company previously announced.

Immorta Bio Inc, a science-based Life Extension company has announced patent filing on successful treatment of the carbon tetrachloride model of liver failure using its PMSC-11 stem cell therapy.

Lucius Partners, LLC (“LP”) today announced that its portfolio company, AerWave Medical, Inc., has treated its first two patients in its First-in-Human Trial (FIH).

Artificial intelligence won’t replace people in biopharma, but it is infiltrating every step of drug development, including in some ways that aren’t so obvious.

Enzolytics, Inc. has partnered with The Khalpey AI Lab to improve organ recovery, longevity, and the science of aging by combining drug development with artificial intelligence.

Cardio Diagnostics Holdings, Inc., an AI-driven precision cardiovascular medicine company, announces that Houston-based resTOR Longevity Clinic will integrate Cardio Diagnostics’ solutions into its battery of tests for new patients in its longevity-focused concierge clinic.

Allosteric Bioscience, Inc. (ABI) has signed a Sponsored Research Agreement (SRA) with Dr. Susan Michaelis at Johns Hopkins University for analysis of chemical leads for modulation (increase or decrease) of key protein targets for Optimizing Aging and Longevity.